Completion of a "First in Human" Clinical Phase I Study with a Therapeutic Protein Derived from CAP® Cells
CEVEC Pharmaceuticals ("CEVEC"), the developer of a novel human expression system derived from amniocytes (CAP® Cells),…
CEVEC Pharmaceuticals ("CEVEC"), the developer of a novel human expression system derived from amniocytes (CAP® Cells),…
Alloksys Life Sciences BV (Bunnik, The Netherlands), CEVEC Pharmaceuticals GmbH (Cologne, Germany) and PharmaCell BV (Ma…